Influence of mould-active antifungal treatment on the performance of the Aspergillus-specific bronchoalveolar lavage fluid lateral-flow device test.
about
Point of Care Testing for the Diagnosis of Fungal Infections: Are We There Yet?A Review of Diagnostic Methods for Invasive Fungal Diseases: Challenges and Perspectives.Diagnostic Performance of Contrast Enhanced Pulmonary Computed Tomography Angiography for the Detection of Angioinvasive Pulmonary Aspergillosis in Immunocompromised Patients.Special considerations for the diagnosis and treatment of invasive pulmonary aspergillosis.Diagnostics and susceptibility testing in Aspergillus.Specificity of mannan antigen and anti-mannan antibody screening in patients with haematological malignancies at risk for fungal infection.Galactomannan testing and Aspergillus PCR in same-day bronchoalveolar lavage and blood samples for diagnosis of invasive aspergillosis.Lateral Flow Assays for the Diagnosis of Invasive Aspergillosis: Current Status.Diagnosis, classification, and therapeutic interventions for sinopulmonary Aspergillosis.Invasive aspergillosis in patients with underlying liver cirrhosis: a prospective cohort study.Diagnostic performance of 1,3-beta-D-glucan serum screening in patients receiving hematopoietic stem cell transplantation.Testing the performance of a prototype lateral flow device using bronchoalveolar lavage fluid for the diagnosis of invasive pulmonary aspergillosis in high-risk patients.Levels of interleukin (IL)-6 and IL-8 are elevated in serum and bronchoalveolar lavage fluid of haematological patients with invasive pulmonary aspergillosis.The current management landscape: aspergillosis.Clinical evaluation of the newly formatted lateral-flow device for invasive pulmonary aspergillosis.Bronchoalveolar lavage triacetylfusarinine C (TAFC) determination for diagnosis of invasive pulmonary aspergillosis in patients with hematological malignancies.Real-world challenges and unmet needs in the diagnosis and treatment of suspected invasive pulmonary aspergillosis in patients with haematological diseases: An illustrative case study.[Aspergillus in airway material : Ignore or treat?]Spotlight on isavuconazole in the treatment of invasive aspergillosis and mucormycosis: design, development, and place in therapy.The Serum Level of IL-1B Correlates with the Activity of Chronic Pulmonary AspergillosisEvaluation of Galactomannan Testing, the -Specific Lateral-Flow Device Test and Levels of Cytokines in Bronchoalveolar Lavage Fluid for Diagnosis of Chronic Pulmonary AspergillosisTreatment of Aspergillosis
P2860
Q26746020-FEBDFE7C-F693-4733-95B5-D98F6572E25AQ33732549-EABB8405-4CC9-47D8-A182-D6301E1761A1Q33860940-03DA909B-58FA-48B4-8E24-7E6B786DD3DDQ36396166-14CCA84C-C095-4616-A91D-FECDD56C0FECQ38723910-6FF81FB7-BEA8-453C-9500-652A6BD52600Q38979163-35230A64-2068-46FC-8AF2-E4BD0440EF4AQ38983367-1E9478A5-4B27-4795-A15F-021E3D912857Q39062930-CC73A76F-357B-4841-B29D-E409B719B4A4Q39091924-2B5BF31F-BF69-48A7-8D11-B7E20D9D6739Q39367482-B56FA56C-FCDA-4D0D-B0C4-6CC5CB2F6AC2Q39391519-EBA3CBBE-29AE-4628-8EAC-8586D922037CQ40047106-6A8207EB-DFE6-43A0-AD25-0F6444C5C4F2Q40064394-D812D798-A496-49B2-9A17-C3D4DAD42C79Q40438379-C2085836-EB5E-4DDA-9884-8A977024ACA1Q41996921-6D94C541-3363-4C50-886B-78D2EA0A22F9Q46983540-73A70DF1-FB85-4003-AA2C-19269B5245CFQ48350049-8B2CD0CC-CB52-420E-9190-4252A71A0CE3Q49546197-B31B57F6-50D4-4753-8A14-0ED87FBC9CFBQ54214603-EBCBCF64-72D4-4935-AC03-91A0675FA55FQ58548856-00DB692F-30C4-40EC-9B6E-CD81E8B922CFQ58586647-9BF208DD-7387-446F-BD01-BA4F415DB435Q58765898-D7F5FC77-3AF0-477B-98E7-4669347BD67B
P2860
Influence of mould-active antifungal treatment on the performance of the Aspergillus-specific bronchoalveolar lavage fluid lateral-flow device test.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Influence of mould-active anti ...... luid lateral-flow device test.
@en
type
label
Influence of mould-active anti ...... luid lateral-flow device test.
@en
prefLabel
Influence of mould-active anti ...... luid lateral-flow device test.
@en
P2093
P50
P1476
Influence of mould-active anti ...... luid lateral-flow device test.
@en
P2093
Birgit Spiess
Christopher R Thornton
Frederike Reischies
Holger Flick
Ines Zollner-Schwetz
Mark Reinwald
Peter Neumeister
Reinhard B Raggam
Robert Krause
Susanne Eigl
P304
P356
10.1016/J.IJANTIMICAG.2015.05.017
P577
2015-06-30T00:00:00Z